Register
Login:
Share:
Email Facebook Twitter




Add Surgical Innovations to quick picks

Surgical Innovations Share Price (SUN)



Share Price Information for Surgical Innovations (SUN)


Share Price: 1.375Bid: 1.25Ask: 1.50Change: 0.00 (0.00%)No Movement on Surgical Innov.
Spread: 0.25Spread as %: 20.00%Open: 1.375High: 1.375Low: 1.375Yesterday’s Close: 1.375
InfoGet Live Streaming Prices for SUN - Click here to start your 30 day FREE trial today.


Surgical Innovations Group Plc Ord 1P

Surgical Innovations is listed in the FTSE AIM All-Share
Surgical Innovations is part of the Health Care Equipment & Services sector






Share Price SpacerPrice
1.375

Share Price SpacerBid
1.25

Share Price SpacerAsk
1.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
32,647

Share Price SpacerOpen
1.375

Share Price SpacerHigh
1.375

Share Price SpacerLow
1.375

Share Price SpacerClose
1.375

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 485.06m £6.67m 20,000

52 Week High 5.38 52 Week High Date 31-JUL-2014
52 Week Low 1.05 52 Week Low Date 7-NOV-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1 32,647 0 -0.628 -2.19 0.00 0.00


London South East Users info for Surgical Innovations




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Jul-15
14:56:23
1.26
32,647
Sell* 
1.25
1.50
411.35
Trade Type:
Ordinary

27-Jul-15
12:03:35
1.26
21,709
Sell* 
1.25
1.50
273.53
Trade Type:
Ordinary

27-Jul-15
10:19:48
1.4374
6,125
Buy* 
1.25
1.50
88.04
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Surgical Innovations trades >>

Directors Deals for Surgical Innovations (SUN)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-Dec-14Exercise of option
Trade Notifier Information for Surgical Innovations Group
Michael John McMahon held the position of Non-Executive Director at Surgical Innovations Group at the time of this trade.
 Michael John McMahon
1.7GBX400,00017618511
17-Nov-14Buy
Trade Notifier Information for Surgical Innovations Group
Christopher John Rea held the position of Managing Director at Surgical Innovations Group at the time of this trade.
 Christopher John Rea
1.3GBX30,354,89269814083
11-Nov-13Exercise of option
Trade Notifier Information for Surgical Innovations Group
Graham Bowland held the position of CEO and Company Secretary at Surgical Innovations Group at the time of this trade.
 Graham Bowland
1.5GBX140,0005168498
View more Surgical Innovations directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
30 Jun '15
mannnan
Jolly
1.38
No Opinion

Again again
30 Jun '15
jollyspeculator
covenant rns
1.38
Strong Sell

Extract "The Company currently has a term loan of £3 million from Yorkshire Bank which is repayable in April 2017. After taking account of cash balances, net indebtedness to Yorkshire Bank was £1.54 million at close of business on 29 June 2015. The term loan carries a number of financial covenants, including a profitability covenant requiring EBITDA (earnings before interest, tax, depreciation and amortisation) of a minimum of £600,000 for the year ending 31 December 2015 (the "EBITDA covenant"). The Board is now of the view that the Company is unlikely to be able to meet the EBITDA covenant and is therefore commencing formal discussions with Yorkshire Bank in relation to this matter. Further announcements will be made as appropriate." ...DYOR, all...opinion only, of course
3 Jun '15
2reincarnated
3cardbrag
2.00
No Opinion

like a rights issue?
2 Jun '15
3cardbrag
Steady upward pressure
2.13
No Opinion

in recent days and some decent buys. Wonder if something is about to happen here
12 May '15
Troajan
mannan
1.88
No Opinion

looks pretty good this. the workforce got a pay rise last year,so someones optimistic on the board.
12 May '15
mannnan
sun
1.38
No Opinion

Surgical Innovations Group plc ("SI" or the "Group" or the "Company") Final Results Surgical Innovations Group plc (AIM: SUN) today announces its preliminary results for the financial year ended 31 December 2014. Summary · Revenue of £4.029 million (2013 restated: £7.478 million) · EBITDA loss, adjusted to exclude exceptional items, of £52,000 (2013 restated: profit of £1.681 million) · Exceptional items of £8.388 million, of which £7.797 million were non-cash impairment charges · Loss before tax of £9.829 million (2013 restated: £44,000) · Refinancing successfully completed during November 2014 comprising new investment of £1.5 million and refinancing of existing £3 million term loan · Cash balance of £678,000 at 31 December 2014, with subsequent cash generation during Q1 2015 Doug Liversidge, Non-executive Chairman, commented: "The financial performance for 2014 was extremely disappointing. However, the Board and staff of SI have worked tirelessly over the last six months with the key objective of restructuring the business to secure a sustainable future for the Group. "Following a turbulent 2014, the Group now has a stronger platform to support the business over the medium term. The Board remains committed to cash generation and the Directors are satisfied with the progress made since the refinancing was announced in November 2014."

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Surgical Innovations (SUN) >>
Please Login or Register to post messages



Surgical Innovations Group Plc Ord 1P home pageWebsite: Surgical Innovations Group Plc Ord 1P
Website Description: surgical innovations group plc



Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.